Literature DB >> 17482317

Responses of the mitochondrial alpha-ketoglutarate dehydrogenase complex to thiamine deficiency may contribute to regional selective vulnerability.

Q Shi1, S S Karuppagounder, H Xu, D Pechman, H Chen, G E Gibson.   

Abstract

Thiamine-dependent enzymes are diminished in multiple neurodegenerative diseases. Thiamine deficiency (TD) reduces the activity of thiamine dependent-enzymes [e.g., the alpha-ketoglutarate dehydrogenase complex (KGDHC)], induces regional selective neurodegeneration and serves as a model of a mild impairment of oxidative metabolism. The current experiments tested whether changes in KGDHC protein subunits (E1k, E2k and E3) or activity or message levels underlie the selective loss of neurons in particular brain regions. Thus, TD-induced changes in these variables in the brain region most vulnerable to TD [the sub-medial thalamic nucleus (SmTN)] were compared to those in a region that is relatively resistant to TD (cortex) at stages of TD when the neuron loss in SmTN is not present, minimal or severe. Impaired motor performance on rotarod was apparent by 8 days of TD (-32%) and was severe by 10 days of TD (-97%). At TD10, the overall KGDHC activity measured by an in situ histochemical staining method declined 52% in SmTN but only 20% in cortex. Reductions in the E2k and E3 mRNA in SmTN occurred as early as TD6 (-28 and -18%, respectively) and were more severe by TD10 (-61 and -66%, respectively). On the other hand, the level of E1k mRNA did not decline in SmTN until TD10 (-48%). In contrast, TD did not alter mRNA levels of the subunits in cortex at late stages. Western blots and immunocytochemistry revealed different aspects of the changes in protein levels. In SmTN, the immunoreactivity of E1k and E3 by Western blotting increased 34 and 40%, respectively, only at TD8. In cortex, the immunoreactivity of the three subunits was not altered. Immunocytochemical staining of brain sections from TD10 mice indicated a reduction in the immunoreactivity of all subunits in SmTN, but not in cortex. These findings demonstrate that the response of the KGDHC activity, mRNA and immunoreactivity of E1k, E2k and E3 to TD is region and time dependent. Loss of KGDHC activity in cortex is likely related to post-translational modification rather than a loss of protein, whereas in SmTN transcriptional and post-translational modifications may account for diminished KGDHC activity. Moreover, the earlier detection in TD induced-changes of the transcripts of KGDHC indicates that transcriptional modification of the two subunits (E2k and E3) of KGDHC may be one of the early events in the cascade leading to selective neuronal death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482317      PMCID: PMC2753422          DOI: 10.1016/j.neuint.2007.03.010

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  43 in total

1.  Quantitative alpha-ketoglutarate dehydrogenase activity staining in brain sections and in cultured cells.

Authors:  L C Park; N Y Calingasan; K F Sheu; G E Gibson
Journal:  Anal Biochem       Date:  2000-01-01       Impact factor: 3.365

2.  A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes.

Authors:  L J Reed
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

3.  Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy.

Authors:  L C Park; D S Albers; H Xu; J G Lindsay; M F Beal; G E Gibson
Journal:  J Neurosci Res       Date:  2001-12-01       Impact factor: 4.164

Review 4.  The role of the cholinergic system in thiamin deficiency.

Authors:  G Gibson; L Barclay; J Blass
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

Review 5.  Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits.

Authors:  G E Gibson; L C Park; H Zhang; S Sorbi; N Y Calingasan
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

6.  Thiamine deficiency induces endoplasmic reticulum stress in neurons.

Authors:  X Wang; B Wang; Z Fan; X Shi; Z-J Ke; J Luo
Journal:  Neuroscience       Date:  2006-11-28       Impact factor: 3.590

7.  Increased brain endothelial nitric oxide synthase expression in thiamine deficiency: relationship to selective vulnerability.

Authors:  Milarca Kruse; Darren Navarro; Paul Desjardins; Roger F Butterworth
Journal:  Neurochem Int       Date:  2004-07       Impact factor: 3.921

8.  Reversal of thiamine deficiency-induced neurodegeneration.

Authors:  Zun-Ji Ke; Lorraine A DeGiorgio; Bruce T Volpe; Gary E Gibson
Journal:  J Neuropathol Exp Neurol       Date:  2003-02       Impact factor: 3.685

Review 9.  Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism.

Authors:  Zun-Ji Ke; Gary E Gibson
Journal:  Neurochem Int       Date:  2004 Jul-Aug       Impact factor: 3.921

10.  Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal.

Authors:  G E Gibson; H Ksiezak-Reding; K F Sheu; V Mykytyn; J P Blass
Journal:  Neurochem Res       Date:  1984-06       Impact factor: 3.996

View more
  11 in total

1.  Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins.

Authors:  Lichuan Yang; Qingli Shi; Daniel J Ho; Anatoly A Starkov; Elizabeth J Wille; Hui Xu; H L Chen; Steven Zhang; Cliona M Stack; Noel Y Calingasan; Gary E Gibson; M Flint Beal
Journal:  Neurobiol Dis       Date:  2009-08-04       Impact factor: 5.996

2.  Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR-743a.

Authors:  Qingli Shi; Gary E Gibson
Journal:  J Neurochem       Date:  2011-06-24       Impact factor: 5.372

3.  Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia.

Authors:  Antonio Costantini; Tiziana Laureti; Maria Immacolata Pala; Marco Colangeli; Simona Cavalieri; Elisa Pozzi; Alfredo Brusco; Sandro Salvarani; Carlo Serrati; Roberto Fancellu
Journal:  J Neurol       Date:  2016-08-03       Impact factor: 4.849

4.  Inactivation and reactivation of the mitochondrial α-ketoglutarate dehydrogenase complex.

Authors:  Qingli Shi; Hui Xu; Haiqiang Yu; Nawei Zhang; Yaozu Ye; Alvaro G Estevez; Haiteng Deng; Gary E Gibson
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

Review 5.  Oxidative stress and transcriptional regulation in Alzheimer disease.

Authors:  Qingli Shi; Gary E Gibson
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Oct-Dec       Impact factor: 2.703

6.  Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism.

Authors:  Guang Yang; Ya Meng; Wenxia Li; Yue Yong; Zhiqin Fan; Hanqing Ding; Youzhen Wei; Jia Luo; Zun-Ji Ke
Journal:  Brain Pathol       Date:  2010-11-03       Impact factor: 6.508

7.  Analysis of the Aspergillus fumigatus proteome reveals metabolic changes and the activation of the pseurotin A biosynthesis gene cluster in response to hypoxia.

Authors:  Martin Vödisch; Kirstin Scherlach; Robert Winkler; Christian Hertweck; Hans-Peter Braun; Martin Roth; Hubertus Haas; Ernst R Werner; Axel A Brakhage; Olaf Kniemeyer
Journal:  J Proteome Res       Date:  2011-03-29       Impact factor: 4.466

8.  PKR downregulation prevents neurodegeneration and β-amyloid production in a thiamine-deficient model.

Authors:  F Mouton-Liger; A-S Rebillat; S Gourmaud; C Paquet; A Leguen; J Dumurgier; P Bernadelli; V Taupin; L Pradier; T Rooney; J Hugon
Journal:  Cell Death Dis       Date:  2015-01-15       Impact factor: 8.469

Review 9.  Thiamine and selected thiamine antivitamins - biological activity and methods of synthesis.

Authors:  Adam Tylicki; Zenon Łotowski; Magdalena Siemieniuk; Artur Ratkiewicz
Journal:  Biosci Rep       Date:  2018-01-10       Impact factor: 3.840

Review 10.  Metabolic Therapy of Heart Failure: Is There a Future for B Vitamins?

Authors:  Jérôme Piquereau; Solène E Boitard; Renée Ventura-Clapier; Mathias Mericskay
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.